DAWN vs RJF · rev $131.2M vs rev $15.91B
Day One Biopharmaceuticals Inc (DAWN) versus RJF (RJF) — a side-by-side from cached financials, not a winner call.
Day One Biopharmaceuticals Inc (DAWN) is a biotechnology company listed on US.
RJF (RJF) common stock.
Latest reported DAWN revenue for 2024-12-31 was $131.2M. Net income was -$95.5M. DAWN currently screens at market cap $656.8M.
Latest reported RJF revenue for 2025-09-30 was $15.91B. Net income was $2.13B. Revenue was up 6.6% from 2024-09-30 to 2025-09-30. RJF currently screens at market cap $0.
DAWN currently screens at market cap $656.8M. RJF currently screens at market cap $0.
Not investment advice. Open the DAWN and RJF stock pages for the full models.
Not investment advice.